Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements
Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in...
Saved in:
Published in | Pharmacogenetics (London) Vol. 4; no. 3; p. 117 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
01.06.1994
|
Subjects | |
Online Access | Get more information |
ISSN | 0960-314X |
DOI | 10.1097/00008571-199406000-00002 |
Cover
Loading…
Abstract | Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in urine and plasma of 39 healthy subjects. The measurements allowed determinations of: (1) systemic caffeine clearance (CL(caff)); (2) the caffeine metabolite ratio (AFMU + 1X + 1U)/17U determined in an overnight-urine specimen and referred to as CMR, and (3) the ratio (17X + 17U)/137X measured in urine collected between 4 and 5 h after caffeine intake and referred to as PCUR for 'paraxanthine-caffeine urinary ratio'. The PCUR showed a bimodal distribution and a relatively wide variation, CL(caff) and CMR were both normally distributed. The correlation between CL(caff) and CMR was r = 0.77 (p < 0.001), between CLcaff and PCUR r = 0.46 (p < 0.01), and between CMR and PCUR r = 0.40 (p < 0.02). The difference between the correlation coefficients 0.77 and 0.46 was statistically significant (z-test; p < 0.05). The well established decrease of caffeine metabolism by oral contraceptive use was observed with both CL(caff) and CMR but not with PCUR. Examination of possible explanations for the differences between PCUR and CMR led to the finding of a correlation between PCUR and the renal clearance of caffeine (CLr) with r = -0.47 (p < 0.01). Further scrutiny demonstrated that a bimodal or non-normal frequency distribution as shown by PCUR was also shown by CLr and by urine flow rate. |
---|---|
AbstractList | Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine which served as a standard of reference for such activity. Following a standardized dose, caffeine (137X) and its metabolites were measured in urine and plasma of 39 healthy subjects. The measurements allowed determinations of: (1) systemic caffeine clearance (CL(caff)); (2) the caffeine metabolite ratio (AFMU + 1X + 1U)/17U determined in an overnight-urine specimen and referred to as CMR, and (3) the ratio (17X + 17U)/137X measured in urine collected between 4 and 5 h after caffeine intake and referred to as PCUR for 'paraxanthine-caffeine urinary ratio'. The PCUR showed a bimodal distribution and a relatively wide variation, CL(caff) and CMR were both normally distributed. The correlation between CL(caff) and CMR was r = 0.77 (p < 0.001), between CLcaff and PCUR r = 0.46 (p < 0.01), and between CMR and PCUR r = 0.40 (p < 0.02). The difference between the correlation coefficients 0.77 and 0.46 was statistically significant (z-test; p < 0.05). The well established decrease of caffeine metabolism by oral contraceptive use was observed with both CL(caff) and CMR but not with PCUR. Examination of possible explanations for the differences between PCUR and CMR led to the finding of a correlation between PCUR and the renal clearance of caffeine (CLr) with r = -0.47 (p < 0.01). Further scrutiny demonstrated that a bimodal or non-normal frequency distribution as shown by PCUR was also shown by CLr and by urine flow rate. |
Author | Tang, B K Zhou, Y Kadar, D Kalow, W |
Author_xml | – sequence: 1 givenname: B K surname: Tang fullname: Tang, B K organization: Department of Pharmacology, University of Toronto, Ontario, Canada – sequence: 2 givenname: Y surname: Zhou fullname: Zhou, Y – sequence: 3 givenname: D surname: Kadar fullname: Kadar, D – sequence: 4 givenname: W surname: Kalow fullname: Kalow, W |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/7920691$$D View this record in MEDLINE/PubMed |
BookMark | eNotT19LwzAczMNkbtOPIPy-QDVpmqTxbRT_wUAfFPRpJO0vGFmTkqaDfXsr7l6OO47jbk0WIQYkBBi9ZVSrOzqjFooVTOuKylkVf1a5ICuqJS04qz4vyXocfyhlgvNySZZKl1RqtiLHxjiHPiCYEQwMKVoEFxM0X29sW4Jpsz_6fLqHIWYM2ZsD-OAOE4YWITpIGGbLzbmYRogBpuSDSScYvjHEfBp8CzkZn6FHM04J-7llvCIXzhxGvD7zhnw8Prw3z8Xu9eml2e6KljOaC2WZMEZ3ne5kJbi0Do3jrmZVpZUVtFWKSuOk5ErIzlJez_9N3QqLvKtbWm7IzX_vMNkeu_2QfD-P25__l7-9CV_J |
CitedBy_id | crossref_primary_10_1002_jppr2000303102 crossref_primary_10_1007_s00360_005_0483_3 crossref_primary_10_1046_j_0306_5251_2001_01494_x crossref_primary_10_1016_S0378_4274_98_00346_4 crossref_primary_10_1177_009127009703700121 crossref_primary_10_1016_S0009_9236_97_90045_X crossref_primary_10_1111_j_2042_7158_2011_01326_x crossref_primary_10_2165_00003088_200342150_00006 crossref_primary_10_1016_S0031_3955_05_70338_2 crossref_primary_10_1002_j_2055_2335_2008_tb00845_x crossref_primary_10_1080_17512433_2021_1997585 crossref_primary_10_1016_S0048_9697_01_00732_X crossref_primary_10_1111_j_1365_2125_1995_tb04411_x crossref_primary_10_1046_j_1365_2125_1998_00776_x crossref_primary_10_1111_obr_12869 crossref_primary_10_1186_bcr797 crossref_primary_10_1007_s10517_011_1243_x crossref_primary_10_1186_bcr798 crossref_primary_10_1016_j_freeradbiomed_2003_11_013 crossref_primary_10_1093_carcin_bgn136 crossref_primary_10_3109_00365519609088615 crossref_primary_10_1089_dna_1996_15_273 crossref_primary_10_1371_journal_pone_0183424 crossref_primary_10_1016_S0090_9556_24_14946_X crossref_primary_10_1097_00007691_199610000_00011 crossref_primary_10_1097_00008571_200004000_00001 crossref_primary_10_1097_00007691_200212000_00006 crossref_primary_10_1007_s00228_010_0964_5 crossref_primary_10_1515_DMDI_2004_20_4_247 crossref_primary_10_1016_S0378_4347_98_00016_4 crossref_primary_10_1111_j_1600_0773_1995_tb00134_x crossref_primary_10_1371_journal_pone_0117328 crossref_primary_10_1016_j_fct_2004_01_010 crossref_primary_10_1016_S0378_4274_98_00252_5 crossref_primary_10_1097_00008571_200011000_00004 crossref_primary_10_1515_dmpt_2015_0001 crossref_primary_10_1016_S0031_3955_05_70463_6 crossref_primary_10_1016_S0009_9236_98_90105_9 crossref_primary_10_1046_j_1365_2125_2000_00128_x crossref_primary_10_1016_0306_3623_95_02014_4 crossref_primary_10_1016_j_talanta_2021_122658 crossref_primary_10_1016_S0006_2952_97_00263_3 crossref_primary_10_1078_1438_4639_00088 crossref_primary_10_1128_AAC_46_8_2358_2364_2002 crossref_primary_10_1097_00007691_200008000_00008 crossref_primary_10_1177_074823379701300205 crossref_primary_10_1016_S0278_6915_01_00005_9 crossref_primary_10_1016_S1570_0232_03_00065_5 crossref_primary_10_3109_00365519609090590 crossref_primary_10_1017_S109285290001186X crossref_primary_10_1007_s00228_005_0082_y crossref_primary_10_1097_00004714_199806000_00004 crossref_primary_10_1002_j_1552_4604_1997_tb04321_x |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/00008571-199406000-00002 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 7920691 |
Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | .Z2 123 4Q1 4Q2 4Q3 53G 5RE 5VS 8L- AAAAV AAIQE AAMTA AARTV AAYEP ABBUW ABDIG ABJNI ABXVJ ACDDN ACEWG ACGFS ACILI ACWDW ACWRI ACXNZ ADFPA ADGGA ADHPY ADNKB AE3 AEETU AFDTB AFUWQ AHQNM AHRYX AHVBC AINUH AJCLO AJIOK AJNWD AJNYG AJZMW ALKUP ALMA_UNASSIGNED_HOLDINGS AMJPA AMNEI AWKKM BQLVK BS7 C45 CAG CGR COF CS3 CUY CVF DIWNM DUNZO E.X EBS ECM EIF EJD EX3 F2K F2L F5P FL- IH2 IKREB IN~ JF9 JG8 JK3 JK8 K8S KD2 KMI NPM N~M OAG OAH OCUKA ODA OJAPA OL1 OLG OLV OLW OLZ OPC OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K R58 S4R S4S T8P TEORI VVN W3M WOQ WOW X3V X3W XXN XYM ZFV ZGI ZZMQN |
ID | FETCH-LOGICAL-c310t-7b15aa9dd9d64536bfeaf3f814497b50c7706af663756db038060a8c5be3d8c02 |
ISSN | 0960-314X |
IngestDate | Wed Feb 19 01:21:16 EST 2025 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c310t-7b15aa9dd9d64536bfeaf3f814497b50c7706af663756db038060a8c5be3d8c02 |
PMID | 7920691 |
ParticipantIDs | pubmed_primary_7920691 |
PublicationCentury | 1900 |
PublicationDate | 1994-06-01 |
PublicationDateYYYYMMDD | 1994-06-01 |
PublicationDate_xml | – month: 06 year: 1994 text: 1994-06-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmacogenetics (London) |
PublicationTitleAlternate | Pharmacogenetics |
PublicationYear | 1994 |
SSID | ssj0015332 |
Score | 1.333652 |
Snippet | Two established caffeine-based urinary methods for measuring CYP1A2 activity were compared with each other, and also with the systemic clearance of caffeine... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 117 |
SubjectTerms | Adult Biotransformation Caffeine - administration & dosage Caffeine - pharmacokinetics Caffeine - urine Cytochrome P-450 CYP1A2 Cytochrome P-450 Enzyme System - genetics Cytochrome P-450 Enzyme System - metabolism Female Humans Kidney - metabolism Male Metabolic Clearance Rate Molecular Probes Oxidoreductases - genetics Oxidoreductases - metabolism Phenotype Reference Values |
Title | Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7920691 |
Volume | 4 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEG42SiAX0WjwTR0kl2Rknt093uKqBEHZwwajl9BPIpidxZ0I63_wP1v9mO0hRlEvs0sPDDNdH0VV9VdfEfJMVa1mreWZMUWT1ZbTTJamzQoh8oopVVHqGoXfvafHJ_Xb0-Z0MvkxYi1d9vK5-n5tX8n_WBXX0K6uS_YfLLt5KC7gf7QvXtHCeP0rG0-FtcaFiWJ1IBzVSgYJ7-nHWXFUep0MNxrCZf3Lrne8IC-xEceSuDjxq3HR6DB0B5Hgiu-OSOeoX12_Xn5WfopEf3CRiomrcUQ7i9rX-JLGSz6PZoRsigzzWJV-maqqn867y-T_ncsXOpC9X6WVL-Hk6UOqTQSR4YFDNRQZqfPygYM5-Nt6BKtq5DuL0MT5i08PWsGBUscKx4zBICQ2xPtu7X5k6uWFtzVry5yGMWB_vHlFazve2SJbmHS4Kaqu9BOPpDAu9kdSwydFWtigAHrdu-2Q7fjEK0mLD17mt8mtmHXAUYDQHTIxi12yHeaQrnfJfjTi-hDmqR9vdQj7MEvS5uu75NuAOBArEOARB4g4CIiDAXEvYIM32OANOgsebxDxBt0CIt4g4Q083mCMt3vk5M3r-fQ4i5M7MoXpQp8xWTRCtFq3mtZNRaU1wlaWY_beMtnkirGcCovRLmuolnnFcdcEV400leYqL_fIjUW3MPcJ4O5RoxX-sKJWXHJpmlpzN57atLyUD8he2NmzZZBnOYtb_vB3Nx6RnYTVx-SmRW9gnmBo2cun3uQ_AasadSU |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caffeine+as+a+probe+for+CYP1A2+activity%3A+potential+influence+of+renal+factors+on+urinary+phenotypic+trait+measurements&rft.jtitle=Pharmacogenetics+%28London%29&rft.au=Tang%2C+B+K&rft.au=Zhou%2C+Y&rft.au=Kadar%2C+D&rft.au=Kalow%2C+W&rft.date=1994-06-01&rft.issn=0960-314X&rft.volume=4&rft.issue=3&rft.spage=117&rft_id=info:doi/10.1097%2F00008571-199406000-00002&rft_id=info%3Apmid%2F7920691&rft_id=info%3Apmid%2F7920691&rft.externalDocID=7920691 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-314X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-314X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-314X&client=summon |